August 27, 2016 10:21 PM ET

Life Sciences Tools and Services

Company Overview of Oncoceutics, Inc.

Executive Profile

Wolfgang Oster M.D., Ph.D.

Chief Executive Officer, Oncoceutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 15 different industries.

See Board Relationships
58--

Background

Dr. Wolfgang Oster MD, PhD. is a Co-Founder and Chief Executive Officer at Oncoceutics, Inc. Dr. Oster was a Partner at PolyTechnos Venture-Partners GmbH. Dr. Oster has extensive pharmaceutical experience. He specializes in the Life Science sector. Previously, He served as Chief Operating Officer of Poniard Pharmaceuticals, Inc. He joined PolyTechnos Venture-Partners GmbH in 2003. He joined NeoRx as Chief Operating Officer in June 2001 from U.S. Bioscience, Inc., which ...

Corporate Headquarters

1214 Research Boulevard
Hummelstown, Pennsylvania 17036

United States

Phone: 917-327-6423
Fax: --

Board Members Memberships

Chairman
Director
Director
Executive Chairman
Chairman

Education

Unknown/Other Education
University of Mainz, Germany
BS 1982
University of Mainz, Germany
Post-Doctoral Training
University of Mainz, Germany
PhD 1992
University of Freiburg

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oncoceutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.